Viyash Scientifi

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE807F01027
  • NSEID: VIYASH
  • BSEID: 512529
INR
201.60
-7.45 (-3.56%)
BSENSE

Feb 06

BSE+NSE Vol: 6.83 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Viyash Scientifi
Alivus Life
Sanofi India
Strides Pharma
Sanofi Consumer
Marksans Pharma
P & G Health Ltd
Concord Biotech
Rubicon Research
Corona Remedies
OneSource Speci.

Why is Viyash Scientific Ltd ?

1
Weak Long Term Fundamental Strength with a -3.55% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 8.15 times
  • The company has been able to generate a Return on Equity (avg) of 3.90% signifying low profitability per unit of shareholders funds
2
With a growth in Operating Profit of 78.2%, the company declared Outstanding results in Dec 25
  • The company has declared positive results for the last 8 consecutive quarters
  • ROCE(HY) Highest at 18.65%
  • OPERATING PROFIT TO INTEREST(Q) Highest at 10.49 times
  • DEBT-EQUITY RATIO(HY) Lowest at 0.61 times
3
With ROCE of 18.1, it has a Expensive valuation with a 7.5 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 23.72%, its profits have risen by 138.8% ; the PEG ratio of the company is 1.6
4
Rising Promoter Confidence
  • Promoters have increased their stake in the company by 9.1% over the previous quarter and currently hold 61.43% of the company
  • Promoters increasing their stake is a sign of high confidence in the future of the business
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Viyash Scientifi should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Viyash Scientifi for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Viyash Scientifi
23.72%
0.53
44.57%
Sensex
7.07%
0.61
11.53%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
14.17%
EBIT Growth (5y)
12.25%
EBIT to Interest (avg)
2.15
Debt to EBITDA (avg)
9.75
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
1.38
Tax Ratio
31.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.51%
ROCE (avg)
6.30%
ROE (avg)
5.97%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
60
Industry P/E
32
Price to Book Value
10.88
EV to EBIT
30.90
EV to EBITDA
20.62
EV to Capital Employed
7.51
EV to Sales
3.61
PEG Ratio
1.63
Dividend Yield
NA
ROCE (Latest)
18.12%
ROE (Latest)
15.86%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

36What is working for the Company
ROCE(HY)

Highest at 18.65%

OPERATING PROFIT TO INTEREST(Q)

Highest at 10.49 times

DEBT-EQUITY RATIO(HY)

Lowest at 0.61 times

DEBTORS TURNOVER RATIO(HY)

Highest at 5.83 times

NET SALES(Q)

Highest at Rs 858.41 cr

PBDIT(Q)

Highest at Rs 175.63 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 20.46%

PBT LESS OI(Q)

Highest at Rs 100.35 cr.

PAT(Q)

Highest at Rs 65.84 cr.

-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Viyash Scientifi

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 100.35 cr has Grown at 384.55%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 10.49 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Quarterly
Highest at Rs 858.41 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 175.63 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 20.46%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 100.35 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 65.84 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 65.84 cr has Grown at 38.6%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.61 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly
Highest at 5.83 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Viyash Scientifi

Non Operating Income - Quarterly
Highest at Rs 13.98 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income